Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Slusher

Showing results (581-590 of 672) with videos related to

Pageof 68
Sort By:
Pharmaceutics|September 28, 2023
Microglial-Targeted nSMase2 Inhibitor Fails to Reduce Tau Propagation in PS19 MiceMeixiang Huang, Carolyn Tallon, Xiaolei Zhu, et al.
Science Advances|October 3, 2020
Inhibition of neutral sphingomyelinase 2 promotes remyelinationSeung-Wan Yoo, Amit Agarwal, Matthew D Smith, et al.
BMC Neurology|May 1, 2026
Prevalence and aetiology of cerebral palsy among Nigerian children: a systematic review and meta-analysisUdochukwu Michael Diala, Aderonke O Uhunmwangho-Courage, Fatima Abdullahi, et al.
Cancer Research|November 4, 2010
Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1Meghan J Seltzer, Bryson D Bennett, Avadhut D Joshi, et al.
Cell Reports|October 23, 2015
Preventing Allograft Rejection by Targeting Immune MetabolismChen-Fang Lee, Ying-Chun Lo, Chih-Hsien Cheng, et al.
Molecular Imaging|November 16, 2005
High-affinity near-infrared fluorescent small-molecule contrast agents for in vivo imaging of prostate-specific membrane antigenValerie Humblet, Rena Lapidus, Larry R Williams, et al.
Journal of Medicinal Chemistry|July 24, 2015
High Affinity Dopamine D3 Receptor (D3R)-Selective Antagonists Attenuate Heroin Self-Administration in Wild-Type but not D3R Knockout MiceComfort A Boateng, Oluyomi M Bakare, Jia Zhan, et al.
Molecular Cancer|February 10, 2026
CRISPR screen of human pancreatic cancer xenografts identifies a KLF5 proliferation vulnerability through epigenetic modifiers NCAPD2 and MTHFD1Masahiro Maeda, Kenna Sherman, Weiqiang Zhou, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 10, 2023
SIKs Regulate HDAC7 Stabilization and Cytokine Recall in Late-Stage T Cell Effector DifferentiationRachel S Helms, Alberto Marin-Gonzalez, Chirag H Patel, et al.
Plos One|May 27, 2015
Cambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective propertiesMariana Figuera-Losada, Marigo Stathis, Joelle M Dorskind, et al.
Pageof 68

Showing results (581-590 of 672) with videos related to

Sort By:
Pageof 68
Pharmaceutics|September 28, 2023
Microglial-Targeted nSMase2 Inhibitor Fails to Reduce Tau Propagation in PS19 MiceMeixiang Huang, Carolyn Tallon, Xiaolei Zhu, et al.
Science Advances|October 3, 2020
Inhibition of neutral sphingomyelinase 2 promotes remyelinationSeung-Wan Yoo, Amit Agarwal, Matthew D Smith, et al.
BMC Neurology|May 1, 2026
Prevalence and aetiology of cerebral palsy among Nigerian children: a systematic review and meta-analysisUdochukwu Michael Diala, Aderonke O Uhunmwangho-Courage, Fatima Abdullahi, et al.
Cancer Research|November 4, 2010
Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1Meghan J Seltzer, Bryson D Bennett, Avadhut D Joshi, et al.
Cell Reports|October 23, 2015
Preventing Allograft Rejection by Targeting Immune MetabolismChen-Fang Lee, Ying-Chun Lo, Chih-Hsien Cheng, et al.
Molecular Imaging|November 16, 2005
High-affinity near-infrared fluorescent small-molecule contrast agents for in vivo imaging of prostate-specific membrane antigenValerie Humblet, Rena Lapidus, Larry R Williams, et al.
Journal of Medicinal Chemistry|July 24, 2015
High Affinity Dopamine D3 Receptor (D3R)-Selective Antagonists Attenuate Heroin Self-Administration in Wild-Type but not D3R Knockout MiceComfort A Boateng, Oluyomi M Bakare, Jia Zhan, et al.
Molecular Cancer|February 10, 2026
CRISPR screen of human pancreatic cancer xenografts identifies a KLF5 proliferation vulnerability through epigenetic modifiers NCAPD2 and MTHFD1Masahiro Maeda, Kenna Sherman, Weiqiang Zhou, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 10, 2023
SIKs Regulate HDAC7 Stabilization and Cytokine Recall in Late-Stage T Cell Effector DifferentiationRachel S Helms, Alberto Marin-Gonzalez, Chirag H Patel, et al.
Plos One|May 27, 2015
Cambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective propertiesMariana Figuera-Losada, Marigo Stathis, Joelle M Dorskind, et al.
Pageof 68